TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH IL-10 EXPRESSING CELLS

摘要

This present application describes a therapeutic agent for treating acute or chronic graft-versus-host disease using clonal marrow stem cells (cMSCs) as active ingredient.